The gradual intracellular accumulation of tau aggregates into neurofibrillary tangles (NFTs) is a clinical hallmark for diagnosing and staging Alzheimer's disease (AD) [1]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.